- US12291522utility2025Galectin-3 Inhibitors0 cites
- US12286428utility2025Tricyclic Heteroaryl Compounds Useful as IRAK4 Inhibitors0 cites
- US12286424utility2025Small Molecule Inhibitors of Galectin-30 cites
- US12281085utility2025Bisfluoroalkyl-1,4-benzodiazepinone Compounds and Methods of Use Thereof0 cites
- US12281108utility2025Pyrrolidinone Derivatives as Formyl Peptide 2 Receptor Agonists0 cites
- US12282492utility2025Indicating Differences in and Reconciling Data Stored in Disparate Data Storage Devices0 cites
- US12275718utility2025Small Molecule Inhibitors of Galectin-30 cites
- US12275719utility2025Small Molecule Inhibitors of Galectin-30 cites
- US12275720utility2025Small Molecule Inhibitors of Galectin-30 cites
- US12275721utility2025Indazole Carboxamides as Kinase Inhibitors0 cites
- US12269840utility2025Process for the Preparation of a Cyclic Dinucleotide0 cites
- US12269819utility2025Small Molecule Inhibitors of Galectin-30 cites
- US12247058utility2025Nucleic Acids Encoding Modified FGF-21 Polypeptides, Vectors and Cells Containing, and Use Thereof0 cites
- US12241107utility2025Method of Controlling the Pink Color Generated During Antibody Manufacturing0 cites
- US12233028utility2025Piston Valving for Serially Connectable Drug Modules of a Combinatorial Drug Delivery Device0 cites
- US12234483utility2025Methods of Decreasing the Galactose Content of a Recombinant Glycoprotein Expressed in CHO Cells0 cites
- US12226451utility2025FGF-21 Formulations0 cites
- US12227496utility2025Substituted Bicyclic Compounds as Farnesoid X Receptor Modulators0 cites